Up-regulation of caveolin-1 and blood-brain barrier breakdown are attenuated by N-acetylcysteine in thiamine deficiency

Neurochemistry International

Volumn 57, Issue 7, 2010, Pages 830-837

  Beauchesne, Élizabeth ^a   Desjardins, Paul ^a   Butterworth, Roger F ^a   Hazell, Alan S ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blood brain barrier; Caveolin 1; N Acetylcysteine; Oxidative stress; Thiamine deficiency; Wernicke's encephalopathy

Indexed keywords

ACETYLCYSTEINE; CAVEOLIN 1; GLUTATHIONE; HEME OXYGENASE 1; IMMUNOGLOBULIN G; MATRIX METALLOPROTEINASE; NITRIC OXIDE SYNTHASE; OCCLUDIN; PYRITHIAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; C57BL 6 MOUSE; CONTROLLED STUDY; ENDOTHELIUM; EXTRAVASATION; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THALAMUS; THIAMINE DEFICIENCY; UPREGULATION;

ACETYLCYSTEINE; ANIMALS; BLOOD-BRAIN BARRIER; CAVEOLIN 1; DISEASE PROGRESSION; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RANDOM ALLOCATION; SIGNAL TRANSDUCTION; THIAMINE DEFICIENCY; UP-REGULATION;

MUS;

EID: 77958100217     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.08.022     Document Type: Article

References (56)

1. Agarwal R., Shukla G.S. Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochem. Res. 1999, 24:1507-1514.
2. Aoyama K., Matsumura N., Watabe M., et al. Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction. Eur. J. Neurosci. 2008, 27:20-30.
3. Bauer P.M., Yu J., Chen Y., et al. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:204-209.
4. Beauchesne E., Desjardins P., Hazell A.S., et al. Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain. Neurochem. Int. 2009, 55:275-281.
5. Beauchesne E., Desjardins P., Hazell A.S., et al. eNOS gene deletion restores blood-brain barrier integrity and attenuates neurodegeneration in the thiamine-deficient mouse brain. J. Neurochem. 2009, 111:452-459.
6. Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009, 118:103-113.
7. Bucci M., Gratton J.P., Rudic R.D., et al. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat. Med. 2000, 6:1362-1367.
8. Calingasan N.Y., Baker H., Sheu K.R., et al. Blood-brain barrier abnormalities in vulnerable brain regions during thiamine deficiency. Exp. Neurol. 1995, 134:64-72.
9. Calingasan N.Y., Gibson G.E. Vascular endothelium is a site of free radical production and inflammation in areas of neuronal loss in thiamine-deficient brain. Ann. N. Y. Acad. Sci. 2000, 903:353-356.
10. Cao H., Sanguinetti A.R., Mastick C.C. Oxidative stress activates both Src-kinases and their negative regulator Csk and induces phosphorylation of two targeting proteins for Csk: caveolin-1 and paxillin. Exp. Cell Res. 2004, 294:159-171.
11. Chan P.H., Schmidley J.W., Fishman R.A., et al. Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology 1984, 34:315-320.
12. Chen Y., Lu Q., Schneeberger E.E., et al. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol. Biol. Cell 2000, 11:849-862.
13. Dasari A., Bartholomew J.N., Volonte D., et al. Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res. 2006, 66:10805-10814.
14. Farkas E., De Jong G.I., de Vos R.A., Jansen Steur E.N., Luiten P.G. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol. 2000, 100:395-402.
15. Fu A.L., Dong Z.H., Sun M.J. Protective effect of N-acetyl-l-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice. Brain Res. 2006, 1109:201-206.
16. García-Cardeña G., Martasek P., Masters B.S., et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J. Biol. Chem. 1997, 272:25437-25440.
17. García-Cardeña G., Fan R., Shah V., et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998, 392:821-824.
18. Gibson G.E., Calingasan N.Y., Baker H., Gandy S., Sheu K.F. Importance of vascular changes in selective neurodegeneration with thiamine deficiency. Ann. N. Y. Acad. Sci. 1997, 826:516-519.
19. Glenney J.R., Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10517-10521.
20. Harata N., Iwasaki Y. Evidence for early blood-brain barrier breakdown in experimental thiamine deficiency in the mouse. Metab. Brain Dis. 1995, 10:159-174.
21. Harper C., Butterworth R.F. Nutritional and metabolic disorders. Greenfield's Neuropathology 1997, 601-655. Edward Arnold, Cambridge. 6th edn. P. Lantos, D. Graham (Eds.).
22. Hazell A.S., Wang C. Downregulation of complexin I and complexin II in the medial thalamus is blocked by N-acetylcysteine in experimental Wernicke's encephalopathy. J. Neurosci. Res. 2005, 79:200-207.
23. Hazell A.S., Butterworth R.F. Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation. Alcohol Alcohol. 2009, 44:141-147.
24. Helbok R., Beer R., Engelhardt K. Intracerebral haemorrhage in a malnourished patient, related to Wernicke's encephalopathy. Eur. J. Neurol. 2008, 15:e99-e100.
25. Heo J.H., Han S.W., Lee S.K. Free radicals as triggers of brain edema formation after stroke. Free Radic. Biol. Med. 2005, 39:51-70.
26. Heroux M., Butterworth R.F. Animal Models of Neurological Disease 1992, 95-131. Humana Press, New Jersey. A. Boulton, G.B. Baker, R.F. Butterworth (Eds.).
27. Héroux M., Raghavendra Rao V.L., Lavoie J., Richardson J.S., Butterworth R.F. Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease. Metab. Brain Dis. 1996, 11:81-88.
28. Klatzo I. Disturbances of the blood-brain barrier in cerebrovascular disorders. Acta Neuropathol. Suppl. 1983, 8:81-88.
29. Krizbai I.A., Bauer H., Bresgen N., et al. Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells. Cell. Mol. Neurobiol. 2005, 25:129-139.
30. Langlais P.J., Anderson G., Guo S.X., et al. Increased cerebral free radical production during thiamine deficiency. Metab. Brain Dis. 1997, 12:137-143.
31. Lu H., Zhang D.M., Chen H.L., et al. N-acetylcysteine suppresses oxidative stress in experimental rats with subarachnoid hemorrhage. J. Clin. Neurosci. 2009, 16:684-688.
32. McCaffrey G., Staatz W.D., Quigley C.A., et al. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J. Neurochem. 2007, 103:2540-2555.
33. Michel J.B., Feron O., Sacks D., et al. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J. Biol. Chem. 1997, 272:15583-15586.
34. Murphy A.N. In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease. EMBO Mol. Med. 2009, 1:81-84.
35. Nag S., Venugopalan R., Stewart D.J. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta Neuropathol. 2007, 114:459-469.
36. Nakagawa S., Deli M.A., Kawaguchi H., Shimizudani T., Shimono T., Kittel A., Tanaka K., Niwa M. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int. 2009, 54:253-263.
37. Parat M.O., Fox P.L. Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible. J. Biol. Chem. 2001, 276:15776-15782.
38. Parat M.O., Fox P.L. Oxidative stress, caveolae and caveolin-1. Subcell. Biochem. 2004, 37:425-441.
39. Park J.H., Okayama N., Gute D., et al. Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton. Am. J. Physiol. 1999, 277:C1066-C1074.
40. Parton R.G., Simons K. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 2007, 8:185-194.
41. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2003, Academic Press, New York. Third ed.
42. Raynal F., Michot B., Bachellerie J.P. Complete nucleotide sequence of mouse 18S rRNA gene: comparison with other available homologs. FEBS Lett. 1984, 167:263-268.
43. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000, 132:365-386.
44. Schubert W., Frank P.G., Woodman S.E., et al. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J. Biol. Chem. 2002, 277:40091-40098.
45. Shin N.Y., Nam H.S., Lee S.K. Hemorrhagic Wernicke encephalopathy in a patient with liver transplantation. Neurology 2009, 73:1423.
46. Siesjö B.K. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J. Neurosurg. 1992, 77:169-184.
47. Song L., Ge S., Pachter J.S. Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood 2007, 109:1515-1523.
48. Tang Z.L., Scherer P.E., Lisanti M.P. The primary sequence of murine caveolin reveals a conserved consensus site for phosphorylation by protein kinase C. Gene 1994, 147:299-300.
49. Troncoso J.C., Johnston M.V., Hess K.M., et al. Model of Wernicke's encephalopathy. Arch. Neurol. 1981, 38:350-354.
50. Volonte D., Galbiati F., Pestell R.G., et al. Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr(14)) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress. J. Biol. Chem. 2001, 276:8094-8103.
51. Volonte D., Zhang K., Lisanti M.P., et al. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol. Biol. Cell 2002, 13:2502-2517.
52. Vortmeyer A.O., Colmant H.J. Differentiation between brain lesions in experimental thiamine deficiency. Virchows Arch. A. Pathol. Anat. Histopathol. 1988, 414:61-67.
53. Xiong Y., Peterson P.L., Lee C.P. Effect of N-acetylcysteine on mitochondrial function following traumatic brain injury in rats. J. Neurotrauma 1999, 16:1067-1082.
54. Yang G., Truong L.D., Timme T.L. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 1998, 4:1873-1880.
55. Zhong Y., Smart E.J., Weksler B., et al. Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J. Neurosci. 2008, 28:7788-7796.
56. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.